Intelligent Optoacoustic Radiomics via Synergistic Integration of System Models and Medical Knowledge
EchoLux aims to revolutionize radiomics by integrating imaging hardware, medical knowledge, and Bayesian reasoning for explainable diagnostics in optoacoustic imaging of peripheral neuropathy.
Projectdetails
Introduction
Radiomics - the extraction of clinically relevant information from complex medical imaging data via mathematics and data science - is on the verge of becoming a main player in clinical research and medicine. However, the current radiomics workflow mostly relies on feature engineering and black box machine learning, lagging behind the state-of-the-art in explainable artificial intelligence.
Objectives
I will exploit my broad expertise in mathematics, informatics, and biomedical imaging to implement intelligent radiomics by integrating the whole imaging value chain - ranging from imaging hardware, over image formation, to medical interpretation of the data - into an intelligent software environment. EchoLux is a paradigm shift from black box machine learning to truly intelligent radiomics.
Implementation Steps
EchoLux will be realized in three steps:
- Modelling the imaging system via a digital twin approach using dedicated physical phantom data and a reference dataset acquired from healthy volunteers.
- Development and integration of a medical knowledge base that captures the effects of disease on the imaged tissue.
- Integration of system and medical tissue models into a Bayesian reasoning framework that is able to perform explainable diagnostics and medical knowledge discovery.
Clinical Use Case
The clinical use case is optoacoustic imaging of peripheral neuropathy. I recently demonstrated that the internal structure and vascular supply of peripheral nerves can be visualized in unprecedented detail by exploiting the molecular contrast of optoacoustic imaging.
Potential Impact
The EchoLux approach, thus, has the potential to enable early detection of pathological changes in peripheral nerves, e.g., in conjunction with diabetes. EchoLux links the clinical imaging data simultaneously back to the hardware and forward to the medical decision making.
Conclusion
This holistic and interdisciplinary approach will leverage radiomics in general and boost the clinical value of optoacoustic imaging.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 1.499.976 |
Totale projectbegroting | € 1.499.976 |
Tijdlijn
Startdatum | 1-7-2022 |
Einddatum | 30-6-2027 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- HELMHOLTZ ZENTRUM MUENCHEN DEUTSCHES FORSCHUNGSZENTRUM FUER GESUNDHEIT UND UMWELT GMBHpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A light-efficient microscope for fast volumetric imaging of photon starved samplesLowLiteScope aims to revolutionize bioluminescence microscopy by using AI-driven light field techniques for high-resolution 3D imaging of biological samples, enhancing research capabilities in life sciences. | ERC Proof of... | € 150.000 | 2024 | Details |
Accurate quantification of neurologic disease over timeThe project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions. | ERC Proof of... | € 150.000 | 2025 | Details |
All-optical photoacoustic imaging for neurobiologyDeveloping advanced sensors for high-speed, high-sensitivity photoacoustic imaging to non-invasively capture single-neuron activity deep in the mouse brain. | ERC Starting... | € 1.499.667 | 2024 | Details |
MUlti-spectral Scattering matrix for Enhanced skin imagingThe ERC REMINISCENCE project developed the DeepInsight microscope, enabling advanced non-invasive 3D imaging for early melanoma detection and skin disease analysis, with plans for commercialization. | ERC Proof of... | € 150.000 | 2024 | Details |
In vivo Immunofluorescence-Optical Coherence TomographyDevelop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease. | ERC Advanced... | € 2.500.000 | 2025 | Details |
A light-efficient microscope for fast volumetric imaging of photon starved samples
LowLiteScope aims to revolutionize bioluminescence microscopy by using AI-driven light field techniques for high-resolution 3D imaging of biological samples, enhancing research capabilities in life sciences.
Accurate quantification of neurologic disease over time
The project aims to develop CHRONOS, an AI-driven diagnostic tool using synthetic biomaps to enable earlier and more accurate detection of brain tumors, facilitating timely clinical decisions.
All-optical photoacoustic imaging for neurobiology
Developing advanced sensors for high-speed, high-sensitivity photoacoustic imaging to non-invasively capture single-neuron activity deep in the mouse brain.
MUlti-spectral Scattering matrix for Enhanced skin imaging
The ERC REMINISCENCE project developed the DeepInsight microscope, enabling advanced non-invasive 3D imaging for early melanoma detection and skin disease analysis, with plans for commercialization.
In vivo Immunofluorescence-Optical Coherence Tomography
Develop a high-resolution endoscopic imaging system combining Optical Coherence Tomography and fluorescent antibodies for improved diagnosis and treatment of esophageal cancer and lung disease.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images. | EIC Pathfinder | € 2.744.300 | 2022 | Details |
Multivariate optoacoustic sensor for longitudinal diabetes monitoringMOSAIC aims to develop a portable, non-invasive optoacoustic sensor powered by explainable AI to monitor diabetes, enhancing early detection and treatment while reducing healthcare costs. | EIC Pathfinder | € 2.997.921 | 2025 | Details |
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technologyDISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI. | EIC Pathfinder | € 3.018.312 | 2022 | Details |
A Novel Handheld Ultrasound Medical Imaging Probe: Prototyping, Initial Validation and Business DevelopmentThe LucidWave Project aims to develop a low-cost, advanced handheld ultrasound probe for improved bedside diagnostics, enhancing medical decision-making and reducing misdiagnosis. | EIC Transition | € 2.427.025 | 2022 | Details |
integrated nano-photonic OMICs bio-SENSor for lung cancerOMICSENS aims to develop a novel nano-photonic omics bio-sensor for real-time detection of TKI resistance in NSCLC, enhancing prognosis and paving the way for personalized cancer treatment. | EIC Pathfinder | € 2.372.318 | 2024 | Details |
Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging.
The project aims to revolutionize breast cancer imaging by developing adjoint-based algorithms for uncertainty quantification, enhancing diagnostic confidence through high-resolution, radiation-free images.
Multivariate optoacoustic sensor for longitudinal diabetes monitoring
MOSAIC aims to develop a portable, non-invasive optoacoustic sensor powered by explainable AI to monitor diabetes, enhancing early detection and treatment while reducing healthcare costs.
On-chip tomographic microscopy: a paraDIgm Shift for RevolUtionizing lab-on-a-chiP bioimaging technology
DISRUPT aims to revolutionize biomedical imaging with a novel lab-on-chip technology for cost-effective, high-resolution cancer detection and diagnostics using integrated tomographic microscopy and AI.
A Novel Handheld Ultrasound Medical Imaging Probe: Prototyping, Initial Validation and Business Development
The LucidWave Project aims to develop a low-cost, advanced handheld ultrasound probe for improved bedside diagnostics, enhancing medical decision-making and reducing misdiagnosis.
integrated nano-photonic OMICs bio-SENSor for lung cancer
OMICSENS aims to develop a novel nano-photonic omics bio-sensor for real-time detection of TKI resistance in NSCLC, enhancing prognosis and paving the way for personalized cancer treatment.